ERK1/2 is positioned upstream of the inflammatory pathway in cisplatin-AKI, and treatment with a MEK (MAPK/ERK kinase) inhibitor, UO126, suppresses cisplatin-induced renal inflammation and kidney cell apoptosis in mice [55, 56]. This evidence concerns the gene MAPK3 and acute kidney injury.